W.R. Berkley Corp’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-530,497
| Closed | -$6.02M | – | 161 |
|
|
2024
Q2 | $6.02M | Buy |
530,497
+200
| +0% | +$2.27K | 0.25% | 47 |
|
|
2024
Q1 | $5.87M | Buy |
530,297
+114,402
| +28% | +$1.27M | 0.33% | 47 |
|
|
2023
Q4 | $4.55M | Buy |
415,895
+274,933
| +195% | +$3.01M | 0.33% | 52 |
|
|
2023
Q3 | $1.52M | Buy |
140,962
+4,874
| +4% | +$52.4K | 0.1% | 145 |
|
|
2023
Q2 | $1.43M | Buy |
136,088
+31,579
| +30% | +$333K | 0.09% | 144 |
|
|
2023
Q1 | $1.08M | Buy |
+104,509
| New | +$1.08M | 0.07% | 141 |
|